Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets

Area of Science:

• Pharmacology
• Cell Biology
• Biochemistry

Background:

• Selective serotonin reuptake inhibitors (SSRIs) are widely used antidepressants.
• Their effects on intracellular calcium signaling, particularly in platelets, are not fully understood.
• Calmodulin plays a crucial role in calcium-dependent cellular processes.

Purpose of the Study:

• To compare the effects of SSRIs (sertraline, paroxetine, fluoxetine) and calmodulin antagonists on intracellular calcium (Ca2+) mobilization in human platelets.
• To investigate the relationship between drug-induced Ca2+ changes and calmodulin inhibition.
• To explore the involvement of inositol trisphosphate (IP3) in these drug effects.

Main Methods:

• Human platelets were treated with SSRIs, imipramine, and calmodulin antagonists (W-7, calmidazolium).
• Intracellular Ca2+ levels were measured under resting and thrombin-stimulated conditions.
• The effect of neomycin, an IP3 inhibitor, on drug-induced Ca2+ changes was assessed.

Main Results:

• All tested SSRIs and calmodulin antagonists enhanced thrombin-induced Ca2+ increases.
• Sertraline, calmidazolium, and W-7 dose-dependently increased baseline intracellular Ca2+.
• A correlation was observed between the capacity to elevate Ca2+ and calmodulin inhibitory potency.
• Neomycin significantly reduced the effects of sertraline, indicating IP3 involvement.

Conclusions:

• SSRIs and calmodulin antagonists modulate intracellular Ca2+ signaling in human platelets.
• The findings suggest that IP3 and calmodulin are involved in the mechanism of action of these drugs.
• This research provides insights into the cellular effects of SSRIs beyond serotonin reuptake inhibition.